III. Contraindications
IV. Mechanism
V. Dosing
- Take 2 mg orally once daily
- Decrease dose to 1 mg/day in eGFR <30 ml/min
VI. Adverse Effects
VII. Safety
- Unknown safety in pregnancy
- Unknown safety in Lactation
VIII. Resources
IX. References
- Olson (2020) Clinical Pharmacology, Medmaster Miami, p. 98
- Hamilton (2020) Tarascon Pocket Pharmacopoeia